The leader of the stem cell unit at the National Institute on Aging says the president’s 2001 policy decision lies at the root of his decision to leave the government for the private sector.


Wired News:

Nearly five years after President Bush announced his restrictive embryonic stem-cell policy, the field is still feeling the fallout. The leader of the stem-cell unit at the National Institute on Aging, part of the National Institutes of Health, announced today he will leave the NIH to join the private sector at a biotech company called Invitrogen in Carlsbad, California.

Dr. Mahendra Rao says the president’s executive order that embryonic stem-cell lines created after Aug. 9, 2001 are not eligible for federal funding, is the reason behind his decision to leave the government agency. He spoke to Wired News about young scientists’ hesitation to enter the field, the danger of hyping stem-cell research, and why he’s still excited about the future of stem-cell research in this Q&A with Wired News.

Link

WAIT BEFORE YOU GO...

This year, the ground feels uncertain — facts are buried and those in power are working to keep them hidden. Now more than ever, independent journalism must go beneath the surface.

At Truthdig, we don’t just report what's happening — we investigate how and why. We follow the threads others leave behind and uncover the forces shaping our future.

Your tax-deductible donation fuels journalism that asks harder questions and digs where others won’t.

Don’t settle for surface-level coverage.

Unearth what matters. Help dig deeper.

Donate now.

SUPPORT TRUTHDIG